9th Spring Meeting


  • Sponsors:
  • Exhibits:
  • Media Partners:



Viral Vectors & Extracellular Vesicles

Chaired By:

Otto-Wilhelm Merten, PhD
Généthon
Mercedes Segura, PhD
bluebird bio Inc.
Aaron Noyes, EngD
Codiak BioSciences

Topics

  • Plasmid Development
  • Upstream Process Development & Scale-Up
  • Potency and High-Throughput Assays
  • Downstream Process Development
  • Formulation, Storage and Stability
  • Product Characterization
  • Analytical Methods Development and Validation
  • Application of Reference Standards & Materials


Cellular Therapies

Chaired By:

Martin A. Giedlin, PhD
Poseida Therapeutics, Inc.
Gary K. Lee, PhD
Sangamo Therapeutics, Inc.
Lisa Stehno-Bittel, PhD
Likarda, LLC

Topics

  • Tissue and Cell Collection
  • Cell Selection
  • Ex Vivo Processing
  • Media Development
  • Feeding, Harvest, and Washing Strategies
  • Cryopreservation and Storage
  • Potency Assays/Dosing
  • Release Testing
  • Formulation and Packaging
  • Transportation
  • Patient Delivery
  • Regulatory Considerations
  • Cell Transfection


Baculovirus Expression Technology

Chaired By:

Dominic Esposito, PhD
Frederick National Laboratory for Cancer Research
António M. Roldão, PhD
Instituto de Biologia Experimental e Tecnológica (iBET)

Topics

  • Human Vaccines: Large-Scale Production and Clinical Trials
  • Veterinary Vaccines
  • Baculoviruses as Insecticides
  • Comparability Studies: BEVS Versus Other Expression Systems
  • Baculovirus-Based Processes in Gene Therapy
  • Advances in Structural Biology Using BEVS
  • Synthetic Biology for BEVS Engineering
  • Systems Biology for Bioprocess Engineering


Viral Vaccines

Chaired By:

Bernd Eichenmueller, PhD
Boehringer Ingelheim Vetmedica, Inc.
Diane Wyatt, PhD
Wyatt CytoConsulting

Topics

  • Cell Line Characterization and Banking
  • Suspension Versus Attachment Dependence
  • Cell Expansion / Scale-Up
  • VLPs Versus Modified Live
  • Media and Process Optimization
  • Animal Component Management
  • Single-Use Systems and Components
  • Infection and Yield Optimization
  • Harvest and Clarification
  • Purification
  • Assay Development
  • Animal Testing

Featured Speakers

Bhupendra Kara, PhD
Head Process Development, Cell & Gene Therapy Platform CMC, GlaxoSmithKline UK
Young Jik Kwon, PhD
Professor, Department of Pharmaceutical Sciences and Department of Chemical Engineering and Materials Science, University of California, Irvine
Chemically Induced Extracellular Vesicles for Versatile Therapies via Facile and Scalable Production and Purification
Gale E. Smith, PhD
Vice President of Vaccine Development, Novavax, Inc.
Udo Reichl
Director, Bioprocess Engineering, Max-Planck-Institute for Dynamics of Complex Technical Systems
High Yield Viral Vaccine Production: Process Options and Monitoring
Inês A. Isidro, PhD
Scientist - Computational Biotechnology, Animal Cell Technology Unit, Instituto de Biologia Experimental e Tecnológica (iBET)
Romy M. Dalton, PhD
Operations Manager, Algenex, Inc.
Peter Czermak
Professor of Bioprocess/Biochemical Engineering, Technische Hochschule Mittelhessen, Fachbereich LSE, Institut für Bioverfahrenstechnik und Pharmazeutische Technologie (IBPT)
Oncolytic Measles Virus Manufacturing: Linking Upstream and Downstream Strategies
Eun Tack "Kevin" Hwang
Associate Scientist, Gene Therapy Purification Process Development, Pfizer, Inc.
Gillian Payne, PhD
Director, Analytical Development, bluebird bio Inc.
Florian Krammer, PhD
Associate Professor, Department of Microbiology, Mount Sinai School of Medicine
Linda Lua, PhD
Director, UQ Protein Expression Facility, University of Queensland
Lawrence C. Thompson, PhD
Principal Scientist and Group Leader, Pfizer, Inc.
Laura A. Palomares, ScD
Researcher and Professor, Universidad Nacional Autónoma de México (UNAM)
Peter Pushko, PhD
President and Chief Scientific Officer, Medigen, Inc.
Nico Lachmann, PhD
Junior Research Group Leader, JRG Translational Hematology of Congenital Diseases, Cluster of Excellence REBIRTH, Hannover Medical School
Robin Levis, PhD
Deputy Director, Division of Viral Products, Office of Vaccines Research and Review, FDA CBER
Yizong Hu
PhD Student, Institute for NanoBioTechnology, Department of Biomedical Engineering, School of Medicine, Johns Hopkins University
Peter Gagnon
Chief Scientific Officer, BIA Separations
Donald L. Jarvis, PhD
Professor, Molecular Biology, University of Wyoming
Behzad Mahdavi, PhD
Vice President, Strategic Innovation & Alliances, Lonza Walkersville, Inc.
Imre Berger, PhD
Director, BrisSynBio Centre for Synthetic Biology, University of Bristol
Eva Rohde
Head of University Clinic for Blood Group Serology and Transfusion Medicine; Director of GMP Laboratory, Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University (PMU)
Rebecca Sendak, PhD
Site Head, Framingham Biopharmaceutics Development, R&D, Sanofi Genzyme
Arifa S. Khan, PhD
Supervisory Microbiologist, Office of Vaccines Research and Review, FDA CBER
Updated Evaluation of the Sf9 Cell Line
Monique M. van Oers, PhD
Professor, Laboratory of Virology, Wageningen University
David A. Theilmann, PhD
Research Scientist, Summerland Research and Development Centre, Agriculture and Agri-Food Canada
Peter Czermak
Professor of Bioprocess/Biochemical Engineering, Technische Hochschule Mittelhessen, Fachbereich LSE, Institut für Bioverfahrenstechnik und Pharmazeutische Technologie (IBPT)
Suitability and Perspectives of Different Insect Cell Factories for the Production of Antimicrobial Peptides
Olli Laitinen, PhD
Researcher, University of Tampere
Wian de Jongh, PhD
CSO, ExpreS2ion Biotechnologies
Andrew Quigley
Membrane Protein Laboratory Coordinator/Group Leader, Diamond Light Source Ltd